NR4A1 and breast cancer: By unsupervised hierarchical clustering analysis of a number of methylation markers and tumours from 148 breast cancer patients, Widschwendter et al. (2004) [52], showed that the tumours segregated naturally into groups with distinct methylation profiles that differed significantly in their hormone receptor status.